breast cancerBreast cancer is one of the most frequently diagnosed cancers among women in the western world. Due to the aggressive behaviour of some specific types and the possibility of an early diagnosis, breast cancer has been constantly studied. Tumour size, histological type, cellular and ...
[translate] aNILCO biomarkers in breast cancer from Chinese patients. 在从中国病人的乳腺癌中的 NILCO 生物标志。[translate]
Biomarkers in Breast Cancer : Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect | Clc Molecular diagnostics for monitoring and predicting therapeutic effect in cancer . Expert Rev. Mol. Diagn. 11 , 9–1210.1586/erm.10.111 [ Cross Ref ]... 被引量: 0发表: 0年 Proteomics and...
Breast cancer is one of the most frequently diagnosed cancers among women in the western world. Due to the aggressive behaviour of some specific types and the possibility of an early diagnosis, breast cancer has been constantly studied. Tumour size, hist
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology, 19 (1991), pp. 403-410 Google Scholar [10] N. Armstrong Overdiagnosis and overtreatment as a quality problem: insights fr...
以乳腺癌为例,在Search Tumor Type栏输入或下拉选择Breast cancer,回车可得到检索结果,共有21个基因及对应的37种药物注释信息,其中Level1~4包含的基因分别为6、2、4和11个,LevelR1~2包含的基因分别为0和2个。页面下拉可以看到不同级别对应的基因名称、突变类型和相关药物。
A newly identified set of protein biomarkers could allow breast cancer screening in breast milk or blood serum. Credit: Danielle Whitham, Clarkson University A simple blood test for women of all ages and risk levels could one day be possible thanks to a new set of protein biomarkers that resea...
Breast cancerPrognosisPredictionClinical utilityBreast cancer is a heterogeneous disease. For the past decades, new technical tools have been developed for biomarkers at the DNA, RNA, and protein levels to better understand the biology of breast cancer. This progress is essential to classify the ...
Lacking of both prognostic biomarkers and therapeutic targets, triple-negative breast cancer (TNBC) underscores pivotal needs to uncover novel biomarkers and viable therapies. MicroRNAs have broad biological functions in cancers and may serve as ideal bi
Breast cancer heterogeneity represents a major hurdle to improve patient survival. Notwithstanding its potential curability due to the availability of treatment modalities that are effective in the presence of favourable clinical or patho-biologic features, there is still a great deal of controversy in ...